![]() |
Volumn 70, Issue 15, 2013, Pages 1342-1346
|
Comparison of the timing of initial prophylactic palivizumab dosing on hospitalization of neonates for respiratory syncytial virus
|
Author keywords
[No Author keywords available]
|
Indexed keywords
PALIVIZUMAB;
ANTIVIRUS AGENT;
MONOCLONAL ANTIBODY;
ARTICLE;
ARTIFICIAL VENTILATION;
COST CONTROL;
FEMALE;
FOLLOW UP;
GESTATIONAL AGE;
HOSPITAL DISCHARGE;
HOSPITAL PATIENT;
HUMAN;
INFECTION CONTROL;
INTENSIVE CARE UNIT;
MAJOR CLINICAL STUDY;
MALE;
NEWBORN;
NEWBORN INFECTION;
OUTCOME ASSESSMENT;
OUTPATIENT;
RESPIRATORY SYNCYTIAL VIRUS INFECTION;
RETROSPECTIVE STUDY;
VIRAL BRONCHIOLITIS;
AMBULATORY CARE;
COMPARATIVE STUDY;
DRUG ADMINISTRATION;
ECONOMICS;
HOSPITALIZATION;
NEWBORN INTENSIVE CARE;
RESPIRATORY SYNCYTIAL VIRUS INFECTIONS;
STATISTICS AND NUMERICAL DATA;
TIME;
TREATMENT OUTCOME;
UNIVERSITY HOSPITAL;
ACADEMIC MEDICAL CENTERS;
AMBULATORY CARE;
ANTIBODIES, MONOCLONAL, HUMANIZED;
ANTIVIRAL AGENTS;
COST SAVINGS;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
HOSPITALIZATION;
HUMANS;
INFANT, NEWBORN;
INTENSIVE CARE UNITS, NEONATAL;
MALE;
RESPIRATORY SYNCYTIAL VIRUS INFECTIONS;
RETROSPECTIVE STUDIES;
TIME FACTORS;
TREATMENT OUTCOME;
|
EID: 84894333192
PISSN: 10792082
EISSN: 15352900
Source Type: Journal
DOI: 10.2146/ajhp120526 Document Type: Article |
Times cited : (12)
|
References (8)
|